Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
172 followers
Regeneron
144 followers
Illumina
81 followers
Agilent Technologies
89 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
49 followers
Explore companies